To improve prediction of resistance development in cancer therapy the physiological regulation of Pgp (ABCB1) and other ABC transporters such as MRPs (ABCCs) and BCRP (ABCG2), with partially overlapping substrate specificities (16–18) need to be considered in more detail. The gene discussed is ABCG2; the disease is cancer.